Literature DB >> 10927170

Diazeniumdiolates: pro- and antioxidant applications of the "NONOates".

A L Fitzhugh1, L K Keefer.   

Abstract

Diazeniumdiolates are compounds containing the X-[N(O)NO](-) structural unit that as a class offer many advantages as tools for probing the roles of nitric oxide (NO) in biological redox processes. Available examples in which X is a secondary amine group spontaneously generate up to two molecules of NO per [N(O)NO](-) unit when dissolved in aqueous media; their half-lives range from 2 s (for X = L-prolyl) to 20 h [for X = (H(2)NCH(2)CH(2))(2)N] at pH 7. 4 and 37 degrees C, and are in general relatively little influenced by medium effects or metabolism. When X = O(-) (Angeli's salt), first-order dissociation produces NO(-) rather than NO, but the ion becomes an NO source on 1-electron oxidation; diazeniumdiolate-derived NO can also be used to generate reactive nitrogen/oxygen species with higher nitrogen oxidation states (+3 and +4) in the presence of selected oxidizing agents. The advantages of diazeniumdiolates in biomedical research are briefly illustrated with examples from the recent literature probing NO's role in inhibiting oxidative drug metabolism, radical-induced lipid oxidation, the cytotoxicity of reactive oxygen species, and ischemia-induced vascular reoxygenation injury. Future work with this compound class should provide further insight into the mechanisms of NO's involvement in pro- and antioxidant processes, and may well lead to important medicinal advances, including reversal of cerebral vasospasm and radiosensitization of hypoxic tumors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10927170     DOI: 10.1016/s0891-5849(00)00251-3

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  19 in total

1.  Nitric oxide inhibits uptake of dopamine and N-methyl-4-phenylpyridinium (MPP+) but not release of MPP+ in rat C6 glioma cells expressing human dopamine transporter.

Authors:  Bo-Jin Cao; Maarten E A Reith
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

Review 2.  Gene expression profiles of NO- and HNO-donor treated breast cancer cells: insights into tumor response and resistance pathways.

Authors:  Robert Y S Cheng; Debashree Basudhar; Lisa A Ridnour; Julie L Heinecke; Aparna H Kesarwala; Sharon Glynn; Christopher H Switzer; Stefan Ambs; Katrina M Miranda; David A Wink
Journal:  Nitric Oxide       Date:  2014-08-19       Impact factor: 4.427

3.  Distinct Nitrite and Nitric Oxide Physiologies in Escherichia coli and Shewanella oneidensis.

Authors:  Qiu Meng; Jianhua Yin; Miao Jin; Haichun Gao
Journal:  Appl Environ Microbiol       Date:  2018-05-31       Impact factor: 4.792

4.  Nitric oxide-regulated proteolysis of human CYP2B6 via the ubiquitin-proteasome system.

Authors:  Choon-Myung Lee; Shweta Tripathi; Edward T Morgan
Journal:  Free Radic Biol Med       Date:  2017-04-17       Impact factor: 7.376

5.  Inhibition of rat platelet aggregation by the diazeniumdiolate nitric oxide donor MAHMA NONOate.

Authors:  Kerry L Homer; Janet C Wanstall
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

6.  Nitric oxide mediates tightening of the endothelial barrier by ascorbic acid.

Authors:  James M May; Zhi-Chao Qu
Journal:  Biochem Biophys Res Commun       Date:  2010-12-13       Impact factor: 3.575

7.  Zn2+-dependent redox switch in the intracellular T1-T1 interface of a Kv channel.

Authors:  Guangyu Wang; Candace Strang; Paul J Pfaffinger; Manuel Covarrubias
Journal:  J Biol Chem       Date:  2007-03-01       Impact factor: 5.157

8.  Regulation of the cardiac muscle ryanodine receptor by O(2) tension and S-nitrosoglutathione.

Authors:  Junhui Sun; Naohiro Yamaguchi; Le Xu; Jerry P Eu; Jonathan S Stamler; Gerhard Meissner
Journal:  Biochemistry       Date:  2008-12-30       Impact factor: 3.162

9.  Photoinduced release of nitroxyl and nitric oxide from diazeniumdiolates.

Authors:  Sergei V Lymar; Vladimir Shafirovich
Journal:  J Phys Chem B       Date:  2007-05-08       Impact factor: 2.991

10.  Conversion of NO2 to NO by reduced coenzyme F420 protects mycobacteria from nitrosative damage.

Authors:  Endang Purwantini; Biswarup Mukhopadhyay
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-26       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.